spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Cell cycle PDB-id
1h28
Asymmetric unit
Main view
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
297 a.a. *
258 a.a. *
Ligands
GLY-SER-ALA-LYS-
ARG-ARG-LEU-PHE-
GLY-GLU

ALA-LYS-ARG-ARG-
LEU-PHE-GLY-GLU

Waters ×37

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
  Biological unit, trimer
- as defined in PDB file (see also PQS)
PDB id: 1h28
Name: Cell cycle
Title: Cdk2/cyclin a in complex with an 11-residue recruitment peptide from p107

Structure:
Cell division protein kinase 2. Chain: a, c. Synonym: cyclin-dependent kinase 2, p33 protein kinase, cdk2. Engineered: yes. Cyclin a2. Chain: b, d. Fragment: cyclin fold, residues 175-432. Synonym: cyclin a.

Source:
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Organism_taxid: 9606

Biological unit:
Trimer (from PDB file)

UniProt:
Chains A, C: P24941 (CDK2_HUMAN)
Pfam   ArchSchema ?
Seq:
Struc:
Seq: 298 a.a.
Struc: 297 a.a.*

Chains B, D: P20248 (CCNA2_HUMAN)
Pfam   ArchSchema ?
Seq:
Struc:
Seq: 432 a.a.
Struc: 258 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

Enzyme class:
Chains A, C: E.C.2.7.11.22   [IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

Reaction:
ATP + a protein = ADP + a phosphoprotein

Resolution:
2.8Å

R-factor:
0.246

R-free:
0.322

Authors:
I.Tews,K.Y.Cheng,E.D.Lowe,M.E.M.Noble,N.R.Brown,S.Gul, S.Gamblin,L.N.Johnson

Key ref:
E.D.Lowe et al. (2002). Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.. Biochemistry, 41, 15625-15634. [PubMed id: 12501191] [DOI: 10.1021/bi0268910]

Date:
31-Jul-02

Release date:
01-Feb-03

Related entries:
1aq1 human cyclin dependent kinase 2 complexed with the inhibitor staurosporine
1b38 human cyclin-dependent kinase 2
1b39 human cyclin-dependent kinase 2 phosphorylated on thr 160
1buh crystal structure of the human cdk2 kinase complex withcell cycle-regulatory protein ckshs1
1ckp human cyclin dependent kinase 2 complexed with the inhibitor purvalanol b
1di8 the structure of cyclin-dependent kinase 2 (cdk2) in complex with 4-[3- hydroxyanilino]-6,7-dimethoxyquinazoline
1dm2 human cyclin-dependent kinase 2 complexed with the inhibitor hymenialdisine
1e1v human cyclin dependent kinase 2 complexed with the inhibitor nu2058
1e1x human cyclin dependent kinase 2 complexed with the inhibitor nu6027
1e9h thr 160 phosphorylated cdk2 - human cyclin a3 complex with the inhibitor indirubin-5- sulphonate bound
... plus others (see Header records)
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
PDBWiki
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PDBbind
PQS
CSA
ProSAT
Whatcheck
Procheck
Go to PROCHECK summary
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1021/bi0268910 Biochemistry 41:15625-15634 (2002)
PubMed id: 12501191  
 
 
Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
E.D.Lowe, I.Tews, K.Y.Cheng, N.R.Brown, S.Gul, M.E.Noble, S.J.Gamblin, L.N.Johnson.
 
  ABSTRACT  
 
Progression through S phase of the eukaryotic cell cycle is regulated by the action of the cyclin dependent protein kinase 2 (CDK2) in association with cyclin A. CDK2/cyclin A phosphorylates numerous substrates. Substrate specificity often employs a dual recognition strategy in which the sequence flanking the phospho-acceptor site (Ser.Pro.X.Arg/Lys) is recognized by CDK2, while the cyclin A component of the complex contains a hydrophobic site that binds Arg/Lys.X.Leu ("RXL" or "KXL") substrate recruitment motifs. To determine additional sequence specificity motifs around the RXL sequence, we have performed X-ray crystallographic studies at 2.3 A resolution and isothermal calorimetry measurements on complexes of phospho-CDK2/cyclin A with a recruitment peptide derived from E2F1 and with shorter 11-mer peptides from p53, pRb, p27, E2F1, and p107. The results show that the cyclin recruitment site accommodates a second hydrophobic residue either immediately C-terminal or next adjacent to the leucine of the "RXL" motif and that this site makes important contributions to the recruitment peptide recognition. The arginine of the RXL motif contacts a glutamate, Glu220, on the cyclin. In those substrates that contain a KXL motif, no ionic interactions are observed with the lysine. The sequences N-terminal to the "RXL" motif of the individual peptides show no conservation, but nevertheless make common contacts to the cyclin through main chain interactions. Thus, the recruitment site is able to recognize diverse but conformationally constrained target sequences. The observations have implications for the further identification of physiological substrates of CDK2/cyclin A and the design of specific inhibitors.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20133761 G.Pascreau, F.Eckerdt, M.E.Churchill, and J.L.Maller (2010).
Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding.
  Proc Natl Acad Sci U S A, 107, 2932-2937.  
19852836 A.Via, C.M.Gould, C.Gemünd, T.J.Gibson, and M.Helmer-Citterich (2009).
A structure filter for the Eukaryotic Linear Motif Resource.
  BMC Bioinformatics, 10, 351.  
19472269 G.Kontopidis, M.J.Andrews, C.McInnes, A.Plater, L.Innes, S.Renachowski, A.Cowan, and P.M.Fischer (2009).
Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
  ChemMedChem, 4, 1120-1128.
PDB codes: 2wev 2wfy 2whb
19039815 M.Orzáez, A.Gortat, L.Mondragón, O.Bachs, and E.Pérez-Payá (2009).
ATP-noncompetitive inhibitors of CDK-cyclin complexes.
  ChemMedChem, 4, 19-24.  
19763085 S.Tyagi, and W.Herr (2009).
E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.
  EMBO J, 28, 3185-3195.  
18410249 A.C.Joerger, and A.R.Fersht (2008).
Structural biology of the tumor suppressor p53.
  Annu Rev Biochem, 77, 557-582.  
18366598 C.J.Oldfield, J.Meng, J.Y.Yang, M.Q.Yang, V.N.Uversky, and A.K.Dunker (2008).
Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners.
  BMC Genomics, 9, S1.  
17373709 G.Lolli, and L.N.Johnson (2007).
Recognition of Cdk2 by Cdk7.
  Proteins, 67, 1048-1059.
PDB code: 2hic
17431409 P.GawliƄski, R.Nikolay, C.Goursot, S.Lawo, B.Chaurasia, H.M.Herz, Y.Kussler-Schneider, T.Ruppert, M.Mayer, and J.Grosshans (2007).
The Drosophila mitotic inhibitor Frühstart specifically binds to the hydrophobic patch of cyclins.
  EMBO Rep, 8, 490-496.  
16584130 J.Sridhar, N.Akula, and N.Pattabiraman (2006).
Selectivity and potency of cyclin-dependent kinase inhibitors.
  AAPS J, 8, E204-E221.  
16707497 K.Y.Cheng, M.E.Noble, V.Skamnaki, N.R.Brown, E.D.Lowe, L.Kontogiannis, K.Shen, P.A.Cole, G.Siligardi, and L.N.Johnson (2006).
The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition.
  J Biol Chem, 281, 23167-23179.
PDB codes: 2cch 2cci
16407256 M.Otyepka, I.Bártová, Z.Kríz, and J.Koca (2006).
Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
  J Biol Chem, 281, 7271-7281.  
17001081 N.Canela, M.Orzáez, R.Fucho, F.Mateo, R.Gutierrez, A.Pineda-Lucena, O.Bachs, and E.Pérez-Payá (2006).
Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A.
  J Biol Chem, 281, 35942-35953.  
16756506 R.P.Bhattacharyya, A.Reményi, B.J.Yeh, and W.A.Lim (2006).
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits.
  Annu Rev Biochem, 75, 655-680.  
15649889 C.Gondeau, S.Gerbal-Chaloin, P.Bello, G.Aldrian-Herrada, M.C.Morris, and G.Divita (2005).
Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation.
  J Biol Chem, 280, 13793-13800.  
15660127 R.Honda, E.D.Lowe, E.Dubinina, V.Skamnaki, A.Cook, N.R.Brown, and L.N.Johnson (2005).
The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles.
  EMBO J, 24, 452-463.
PDB code: 1w98
15701793 T.Gildor, R.Shemer, A.Atir-Lande, and D.Kornitzer (2005).
Coevolution of cyclin Pcl5 and its substrate Gcn4.
  Eukaryot Cell, 4, 310-318.  
15468065 G.M.Verkhivker (2004).
Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: hierarchy of structural loss from all-atom Monte Carlo simulations of p27Kip1 unfolding-unbinding and structural determinants of the binding mechanism.
  Biopolymers, 75, 420-433.  
15343278 N.J.Dibb, S.M.Dilworth, and C.D.Mol (2004).
Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
  Nat Rev Cancer, 4, 718-727.  
15273306 N.Kannan, and A.F.Neuwald (2004).
Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
  Protein Sci, 13, 2059-2077.  
12869192 E.De Moliner, N.R.Brown, and L.N.Johnson (2003).
Alternative binding modes of an inhibitor to two different kinases.
  Eur J Biochem, 270, 3174-3181.
PDB code: 1p5e
14592974 K.Y.Cheng, E.D.Lowe, J.Sinclair, E.A.Nigg, and L.N.Johnson (2003).
The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.
  EMBO J, 22, 5757-5768.
PDB codes: 1q4k 1q4o
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.